| GV-58 |
(2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇 |
1402821-41-3 |
| SULFAPHENAZOLE |
磺胺苯吡唑 |
526-08-9 |
| PRL-3 INHIBITOR I |
PRL-3 INHIBITOR I |
893449-38-2 |
| NS 1738 |
501684-93-1 |
501684-93-1 |
| BIX02189 |
BIX 02189 |
1265916-41-3 |
| Carmustine |
卡莫司汀 |
154-93-8 |
| ATN-161 |
262438-43-7 |
262438-43-7 |
| SP 141 |
6-甲氧基-1-(萘-1-基)-9H-吡啶并[3,4-B]吲哚 |
1253491-42-7 |
| Aftin-4 |
866893-90-5 |
866893-90-5 |
| 1,3-benzoxazol-2-yl 3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl sulfide |
VAS2870 |
722456-31-7 |
| 3-(azepan-1-ylsulfonyl)-N-(3-broMophenyl)benzaMide |
N-(3-溴苯基)-3-[(六氢-1H-氮杂卓-1-基)磺酰基]-苯甲酰胺 |
420831-40-9 |
| troponin I type 3 (cardiac) |
2-((2-氧代-2-(噻吩-2-基)乙基)硫基)-4,6-二(噻吩-2-基)吡啶-3-腈 |
339163-65-4 |
| B-HT 920 DIHYDROCHLORIDE |
盐酸他利克索 |
36085-73-1 |
| H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH |
NFAT INHIBITOR |
249537-73-3 |
| Benzonitrile, 4-[[(1R,2R)-2-[(3R)-3-aMino-1-piperidinyl]-2,3-dihydro-1H-inden-1-yl]oxy]-3-chloro- |
1333210-07-3 |
1333210-07-3 |
| 2-Naphthalenecarboxylic acid, 3-hydroxy-, 2-[(2,4,5-trihydroxyphenyl)Methylene]hydrazide |
DYNGO-4A |
1256493-34-1 |
| ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate |
BRD7552 |
1137359-47-7 |
| Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)- (9CI) |
(1S,2S,5R,6S)-2-氨基二环[3.1.0]己烷-2,6-二羧酸 |
176199-48-7 |
| MAZ51 |
CS-2885 |
163655-37-6 |
| 5-((7-Cl-1H-indol-3-yl)Methyl)-3-MethyliMidazolidine-2,4-dione) |
5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮 |
852391-15-2 |
